管理血管封闭的指南引起的充填剂与排他性的皮肤参与:诊断,分类和治疗的审查
Javier Madero-Pérez1,2, Marta Gil-Martinez3, Cristina Muñoz-Gonzalez4
1Department of Medicine, Universitat Jaume I, Castellón, Spain.
Aesthetic plastic surgery
|August 7, 2025
概括
迅速管理由氨酸 (HA) 填充剂引起的血管堵塞至关重要. 在4-6小时内进行早期干预显著改善了结果,高剂量氨酸酶是主要治疗方法.
科学领域:
- 审美医学是一种美学医学.
- 皮肤病学 皮肤病学
- 整形外科 整形外科 整形外科
背景情况:
- 氨酸 (HA) 填充剂引起的血管封闭会造成永久性组织损伤的风险.
- 及时治疗对于有利的临床结果至关重要,不包括眼部并发症.
- 目前的治疗方案和现代治疗策略需要评估.
研究的目的:
- 审查影响HA填充剂诱导血管封闭的临床结果的关键因素.
- 评估当前的治疗方案和现代治疗策略,以管理这些并发症.
- 为管理血管封闭制定行动指南,重点关注技术和药理方面的问题.
主要方法:
- 对PubMed识别的文章 (96篇相关文章) 的系统文献综述.
- 优先考虑具有重大临床影响的出版物和专家指南.
- 排除了较旧的研究,以与现代的血管体概念和干预性放射学的进步保持一致.
主要成果:
- 疼痛和皮肤颜色变化是血管封闭的主要迹象.
- 在4-6小时内立即干预可以改善预后;在80%的病例中,早期缺血是可逆的.
- 高剂量氨酸酶 (HYAL) 是主要治疗方法;超声波指导降低剂量. 辅助疗法包括抗血小板药物,皮质类固醇,血管扩张剂和高压氧气疗法.
结论:
- 根据目前的血管体概念,准确的诊断和及时的干预是至关重要的.
- 需要标准化指导方针来提高美容医学中患者的安全性和治疗疗效.
- 先进的技术和协议改善了血管封闭的管理.
更多相关视频
相关概念视频
Varicose Veins II: Diagnostic Studies and Interprofessional Care
31
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
31
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Peripheral Artery Disease V: Postoperative Nursing Management
25
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
25
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35


